Successful treatment of mucocutaneous leishmaniasis with liposomal amphotericin b in a patient with hiv
International Journal of Development Research
Successful treatment of mucocutaneous leishmaniasis with liposomal amphotericin b in a patient with hiv
Received 27th January, 2019; Received in revised form 16th February, 2019; Accepted 20th March, 2019; Published online 30th April, 2019
Copyright © 2019, Daniela Zonin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Leishmaniasis is a non-contagious infectious-parasitic disease caused by an etiological agent of the genus Leishmania. Leishmania braziliensis is the main species that causes the disease in Brazil, which is transmitted through the bite of phlebotomid mosquitoes. In this report, a case of localized tegumentary Leishmaniasis with important mucocutaneous involvement is presented in a patient diagnosed concurrently with acquired human immunodeficiency syndrome (AIDS). Despite the aggravating factors, this patient presented excellent therapeutic response after a single cycle of amphotericin B with complete resolution of the lesion.
